A 65-yr. old male who has multiple myeloma is currently rece…
A 65-yr. old male who has multiple myeloma is currently receiving monoclonal anti-CD38 immunotherapy (Daratumumab). Which of the following is used to treat reagent red cells in an effort to prevent interference of this drug with testing in the blood bank?